CAESAREA, Israel,
Sept. 20, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:
DRIO), a leading global digital health company with mobile health
and big data solutions, today announced that it will host a
conference call to provide a business update for investors
at 9:00am EDT on Thursday, October 4,
2018. The conference call will be hosted by Erez
Raphael, Chief Executive Officer, Olivier
Jarry, President and Chief Commercial Officer, Zvi Ben-David, Chief Financial Officer, and Yoav
Shaked, Chairman of the Board. The live conference call can be
accessed by dialing 877-407-8035 or 201-689-8035 (international).
Participants should ask for the DarioHealth Investor Update
Conference Call. The conference call will also be available via
live webcast
at: http://www.investorcalendar.com/event/37592
Conference Call Details:
Date: Thursday, October 4, 2018
Time: 9:00am EDT
Dial-in Number: 877-407-8035
International Dial-in Number: 201-689-8035
Webcast http://www.investorcalendar.com/event/37592
Participants are recommended to dial-in approximately 10 minutes
prior to the start of the event. A replay of the call will be
available approximately two hours after completion
through October 18, 2018. To listen to the replay, dial
877-481-4010 (domestic) or 919-882-2331 (international) and use
replay passcode 37592. The webcast replay will be available
through January 4, 2019.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital
health company serving its users with dynamic mobile health
solutions. In today's day and age, knowledge of health and
treatment is being democratized, and we believe people deserve to
know everything about their own health and have the best tools to
manage their condition. DarioHealth employs a revolutionary
approach whereby harnessing big data, we have developed a novel
method for chronic disease data management, empowering people to
analyze and personalize self-diabetes management in a totally new
way without having the disease slow them down. DarioHealth has a
commercial office in New York with
an R&D center in Caesarea,
Israel. For more information, visit
http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate," or "continue" are intended to identify
forward-looking statements. For example, when the Company describes
it's expected accelerated growth, it is using forward-looking
statements. Readers are cautioned that certain important factors
may affect the Company's actual results and could cause such
results to differ materially from any forward-looking statements
that may be made in this news release. Factors that may affect the
Company's results include, but are not limited to, regulatory
approvals, product demand, market acceptance, impact of competitive
products and prices, product development, commercialization or
technological difficulties, the success or failure of negotiations
and trade, legal, social and economic risks, and the risks
associated with the adequacy of existing cash resources. Additional
factors that could cause or contribute to differences between the
Company's actual results and forward-looking statements include,
but are not limited to, those risks discussed in the Company's
filings with the U.S. Securities and Exchange Commission. Readers
are cautioned that actual results (including, without limitation,
the timing for and results of the Company's commercial and
regulatory plans for Dario™) may differ significantly from those
set forth in the forward-looking statements. The Company undertakes
no obligation to publicly update any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as required by applicable law.
DarioHealth Corporate Contact: Joao Mendes-Roter, VP Marketing,
joao@mydario.com, 1-914-775-5548
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dariohealth-to-host-investor-conference-call-on-october-4-2018-300715981.html
SOURCE DarioHealth Corp.